1,3,5-Triazine Based Hydroxamic Acid Analogues as HDAC Inhibitors: Integrated Modelling by 3D QSAR, Hypogen Pharmacophore Based Virtual Screening and Molecular Dynamic Simulation Studies
Preeti Patel(Indo Soviet Friendship College of Pharmacy), Harish Rajak(Guru Ghasidas Vishwavidyalaya), Naresh Kumar Rangra(Indo Soviet Friendship College of Pharmacy), Mario A. Pagano(University of Padua), Ghanshyam Das Gupta(Indo Soviet Friendship College of Pharmacy), Balak Das Kurmi(Indo Soviet Friendship College of Pharmacy), Ravi Rawat(Universidad Politécnica de El Salvador), N. Navneesh(Indo Soviet Friendship College of Pharmacy), Anna Maria Brunati(University of Padua)
Cited by 2
Related Papers
Solid lipid nanoparticles: a review on recent perspectives and patents
|Expert Opinion on Therapeutic Patents|2020|323
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs
|Life|2023|209
Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
|Pharmacological Reports|2021|145
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
|Drug Delivery and Translational Research|2024|141
Micro- and nanocarrier-mediated lung targeting
|Expert Opinion on Drug Delivery|2010|121